Michael Kody

Felicitex Therapeutics, Inc. is a pre-clinical stage oncology drug development company developing therapies against cancer and diabetes. It operates through the Felicitex Business and TraMeta segments. The Felicitex Business segment handles the design and patents of small molecules and related methods to selectively disrupt dormant cancer cells in a manner that is specific to the disease and tissue context. The TarMeta segment built a drug discovery platform for small molecule inhibitors targeting cancer. The company was founded by Maria Vilenchik and Michael Frid on May 4, 2012 and is headquartered in Natick, MA.

Part of Beach Products, Inc., Pharmaceutical Associates, Inc. is a leading manufacturer and marketer of generic liquid pharmaceuticals. The private company is based in Greenville, SC. The company has been producing better-targeted suspensions, oral solutions, elixirs, syrups, and liquids for almost 50 years. The company offers standard bottle packaging and ready-to-dispense packaging to meet the unique needs of retail chains, independent pharmacies, hospitals, long-term care facilities, and government agencies. Pharmaceutical Associates was the first independent manufacturer to develop vertically integrated unit-dose (ud) packaging and the first to offer complete lines of hard-to-find liquid products in both out-patient and ud packaging. The CEO of the company is Kurt J. Orlofski.

PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY.